Three hundred sixty-degree prophylactic laser retinopexy versus focal laser during rhegmatogenous retinal detachment repair: A systematic review and meta-analysis.

Acta OphthalmolApr 6, 2026 (epub)
Clinical ResearchOphthalmology

Luke Yaldo, Albert Ting, Saif Pasha et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis compared intraoperative 360-degree prophylactic laser with focal laser during pars plana vitrectomy for rhegmatogenous retinal detachment. Thirteen studies involving 3639 eyes were included. Compared with focal laser, 360-degree laser was associated with higher odds of single-surgery anatomic success (OR: 1.82; 95% CI, 1.40-2.39; I 2 = 0%; moderate-certainty). Final visual acuity and visual acuity improvement did not differ, and reported postoperative complications were comparable. The authors note that the evidence was predominantly observational and call for further well-designed randomized trials.

Key findings

  • 360-degree laser was associated with higher odds of single-surgery anatomic success than focal laser (OR: 1.82; 95% CI, 1.40-2.39; I 2 = 0%; moderate-certainty).
  • Final BCVA did not differ between groups (MD = 0.06; 95% CI, -0.01 to 0.13; I 2 = 75.5%).
  • BCVA improvement was similar between groups (MD: -0.06; 95% CI, -0.22 to 0.11; I 2 = 0%).
  • Epiretinal membrane, proliferative vitreoretinopathy, cystoid macular oedema and macular hole rates were comparable between groups.

Why it matters

Anatomic success after retinal detachment repair is clinically important, and the pooled findings suggest that adjunctive 360-degree laser may improve the likelihood of success after one operation. The absence of a measurable visual acuity benefit means the anatomic result should not be interpreted as evidence of better functional outcomes. The predominantly observational evidence also leaves uncertainty about the size and reliability of the association.

What to keep in mind

The evidence was predominantly observational; the authors state that further well-designed randomized trials are needed to clarify the magnitude of benefit.

Source

Published in Acta Ophthalmol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.